EP3353204

BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCER

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    23.9.2016
  • :
    18.10.2023
  • :
    16849686.7
  • :
    22.9.2036
  • :
    BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCER

23.9.2016
18.10.2023
  • :
    Mereo BioPharma 5, Inc.
  • :
    800 W El Camino Real Suite 180, Mountain View, CA 94040, US
  • :
    DUPONT, Jakob
  • :
    Hillsborough, California 94010, US
  • :
    PARMAR, Hema
  • :
    San Mateo, California 94403, US
  • :
    STAGG, Robert Joseph
  • :
    Moraga, California 94556, US
  • :
    201562222505 P
  • :
    23.9.2015
  • :
    US
  • :
    US2016053316
  • :
    23.9.2016
  • :
    C07K 16/22, C07K 16/28, C07K 16/46, A61K 31/282, A61K 39/395